CytoMed Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GDTC and other ETFs, options, and stocks.

About GDTC

CytoMed Therapeutics Ltd. is a biopharmaceutical company, which engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy, and undertaking the research and development of immune cell and stem cell-based therapy. It operates through the Malaysia and Singapore geographical segments. 

CEO
Wee Kiat Tan, PhD
CEOWee Kiat Tan, PhD
Employees
43
Employees43
Headquarters
Singapore, Central Singapore
HeadquartersSingapore, Central Singapore
Founded
2018
Founded2018
Employees
43
Employees43

GDTC Key Statistics

Market cap
25.73M
Market cap25.73M
Price-Earnings ratio
-12.55
Price-Earnings ratio-12.55
Dividend yield
Dividend yield
Average volume
8.02K
Average volume8.02K
High today
$2.13
High today$2.13
Low today
$2.05
Low today$2.05
Open price
$2.13
Open price$2.13
Volume
3.76K
Volume3.76K
52 Week high
$4.05
52 Week high$4.05
52 Week low
$1.20
52 Week low$1.20

People also own

Based on the portfolios of people who own GDTC. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.